Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Emerging Research Fronts Comments

Return to menu of Emerging Research Fronts

ESI Special Topics, December 2005
Citing URL: http://www.esi-topics.com/erf/2005/december05-SanjeevKrishna.html

From •>>December 2005

Sanjeev Krishna answers a few questions about this month's emerging research front in field of Pharmacology & Toxicology:

Pharmacology & Toxicology
Article: Artemisinins target the SERCA of Plasmodium falciparum
Authors: Eckstein-Ludwig, U;Webb, RJ;van Goethem, IDA;East, JM;Lee, AG;Kimura, M;O'Neill, PM;Bray, PG;Ward, SA;Krishna, S
Journal: NATURE, 424 (6951): 957-961, AUG 21 2003
Addresses:
St George Hosp, Sch Med, Dept Cellular & Mol Med, Cranmer Terrace, London SW17 0RE, England.
St George Hosp, Sch Med, Dept Cellular & Mol Med, London SW17 0RE, England.
Univ Southampton, Dept Biochem & Mol Biol, Southampton SO16 7PX, Hants, England.
Osaka City Univ, Sch Med, Radioisotope Ctr, Abeno Ku, Osaka 5458585, Japan.
Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England.
Univ Liverpool, Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Liverpool L3 5QA, Merseyside, England.


ST:  Does it describe a new discovery or a new methodology that's useful to others?


“Artemisinins are drugs that are made from a plant called sweet wormwood (Artemisia annua). Artemisinins work against malaria parasites that have become resistant to other drugs.”

It’s a completely new way of thinking about artemisinins which also provides new methods to study these drugs.

ST:  Could you summarize the significance of your paper in layman's terms?

Malaria is one of our most important diseases, because it kills up to two million children every year. Malaria is caused by a parasite that multiplies in red blood cells. Artemisinins are drugs that are made from a plant called sweet wormwood (Artemisia annua). Artemisinins work against malaria parasites that have become resistant to other drugs. For many years, artemisinins were believed to kill parasites by acting like "dirty bombs" and knocking out many targets in the parasite. We found instead that artemisinins act like very clever bombs, and hit one target very precisely. This target is a molecular motor in parasites that pumps calcium (the SERCA pump of the parasite). SERCA stands for Sarco/Endoplasmic Reticulum Ca2+. Knowing the target for artemisinins is really important because it means that we can now design better artemisinins as well as having the tools to monitor for resistance to these drugs, even before resistance becomes an important problem in practice.

ST:  How did you become involved in this research and were there successes or failures?

I first started this line of research (looking at parasite pumps) when I was doing my Ph.D. studies more than a decade ago. It took quite a long time to work out the best system to study parasite pumps. We use frogs’ eggs, but there are some tricks needed to get them to make pumps of the malaria parasite. Ironing out those wrinkles took a few years.

ST:  What are the social or political implications of your research?

Artemisinin use is increasing greatly, and there is strong political and financial support for providing artemisinins in combination with other types of antimalarial substances to treat malaria effectively. Drug resistance in malaria parasites has made most other antimalarials pretty ineffective. So understanding how these drugs work can make a big difference to how we look out for development of resistance and what the mechanisms of resistance might be. We now have the chance to design our way out of the resistance problem by using our knowledge of the target for artemisinins.End

Sanjeev Krishna
Professor of Molecular Parasitology and Medicine
Division of Cellular and Molecular Medicine
Centre for Infection
St. George’s Hospital
University of London
London, UK

Return to Emerging Research Fronts | Return to Special Topics main menu
 

ESI Special Topics, December 2005
Citing URL: http://www.esi-topics.com/erf/2005/december05-SanjeevKrishna.html

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.